These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12642787)

  • 21. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
    Shohet RV; Vega GL; Anwar A; Cigarroa JE; Grundy SM; Cohen JC
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1975-8. PubMed ID: 10446080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
    Isaacs A; Aulchenko YS; Hofman A; Sijbrands EJ; Sayed-Tabatabaei FA; Klungel OH; Maitland-van der Zee AH; Stricker BH; Oostra BA; Witteman JC; van Duijn CM
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2680-7. PubMed ID: 17440012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint linkage and association analysis of the hepatic lipase promoter polymorphism and lipoprotein size phenotypes.
    Almasy L; Rainwater DL; Cole S; Mahaney MC; Vandeberg JL; Hixson JE; Stern MP; MacCluer JW; Blangero J
    Hum Biol; 2005 Feb; 77(1):17-25. PubMed ID: 16114813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.
    Brunzell JD; Zambon A; Deeb SS
    Biochim Biophys Acta; 2012 Mar; 1821(3):365-72. PubMed ID: 21986251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic lipase polymorphism and increased risk of peripheral arterial disease.
    Eller P; Schgoer W; Mueller T; Tancevski I; Wehinger A; Ulmer H; Foeger B; Haltmayer M; Ritsch A; Patsch JR
    J Intern Med; 2005 Oct; 258(4):344-8. PubMed ID: 16164573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
    Carr MC; Hokanson JE; Zambon A; Deeb SS; Barrett PH; Purnell JQ; Brunzell JD
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2831-7. PubMed ID: 11397895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipase C, Hepatic Type -250A/G (rs2070895) Variant Enhances Carotid Atherosclerosis in Normolipidemic and Asymptomatic Individuals from Brazil.
    Zago VHS; Parra ES; Virgínio VWM; Vendrame F; Gomes ÉIL; Scherrer DZ; Marson FAL; de Faria EC
    Lipids; 2020 May; 55(3):225-237. PubMed ID: 32196671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study.
    Teran-Garcia M; Santoro N; Rankinen T; Bergeron J; Rice T; Leon AS; Rao DC; Skinner JS; Bergman RN; Després JP; Bouchard C;
    Diabetes; 2005 Jul; 54(7):2251-5. PubMed ID: 15983229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic lipase: a pro- or anti-atherogenic protein?
    Jansen H; Verhoeven AJ; Sijbrands EJ
    J Lipid Res; 2002 Sep; 43(9):1352-62. PubMed ID: 12235167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy.
    Yamakawa-Kobayashi K; Somekawa Y; Fujimura M; Tomura S; Arinami T; Hamaguchi H
    Atherosclerosis; 2002 May; 162(1):17-21. PubMed ID: 11947893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
    Yamazaki K; Bujo H; Taira K; Itou N; Shibasaki M; Takahashi K; Saito Y
    Atherosclerosis; 2004 Jan; 172(1):181-7. PubMed ID: 14709374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the hepatic lipase gene and physical activity on coronary heart disease risk.
    Hokanson JE; Kamboh MI; Scarboro S; Eckel RH; Hamman RF
    Am J Epidemiol; 2003 Nov; 158(9):836-43. PubMed ID: 14585761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity.
    Deeb SS; Peng R
    J Lipid Res; 2000 Jan; 41(1):155-8. PubMed ID: 10627514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II.
    Jansen H; Chu G; Ehnholm C; Dallongeville J; Nicaud V; Talmud PJ
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):303-8. PubMed ID: 9974411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population.
    Hubácek JA; Waterworth DM; Pitha J; Humphries SE; Talmud PJ; Poledne R
    Physiol Res; 2001; 50(4):345-51. PubMed ID: 11551139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
    Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
    Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism.
    Ma K; Cilingiroglu M; Otvos JD; Ballantyne CM; Marian AJ; Chan L
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2748-53. PubMed ID: 12601178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.